Neurofibrillary pathology in Alzheimer disease with Lewy bodies - Two subgroups

被引:32
作者
Gearing, M
Lynn, M
Mirra, SS
机构
[1] SUNY Hlth Sci Ctr, Dept Pathol, Brooklyn, NY 11203 USA
[2] Vet Affairs Med Ctr, Atlanta, GA 30033 USA
[3] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
[4] Emory Univ, Sch Publ Hlth, Dept Biostat, Atlanta, GA USA
关键词
D O I
10.1001/archneur.56.2.203
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: While NFT frequency is reportedly reduced in AD+DLB, we often encounter abundant neocortical NFTs in such cases and decided to investigate this discrepancy. Objective: To compare neurofibrillary tangle (NFT) frequency in Alzheimer disease with concomitant dementia with Lewy bodies (AD+DLB) with NFT frequency in "pure" AD. Methods: Neurofibrillary tangle frequency, as well as regional staging of neurofibrillary degeneration modified from Braak, was scored in 160 autopsy cases of primary dementia (80 AD+DLB cases and 80 pure AD cases). Results: Neurofibrillary tangle and modified Braak scores were lower in AD+DLB, as reported previously. Yet, neocortical NFT scores assumed markedly different patterns in the 2 groups (P =.001). In pure AD, NFT scores of "frequent" were predominant: more cases exhibited frequent than moderate or sparse NFTs. In AD+DLB, the distribution of NFT scores was bimodal: NFTs were either frequent or few to absent. Neocortical NFT scores in the AD+DLB group tended to parallel the severity of other types of tau cytopathology (neuropil threads and tau-positive plaque neurites). Conclusions: Cases of AD+DLB may be divided into 2 subgroups based on the extent of neocortical neurofibrillary pathology. These findings could have implications for disease pathogenesis and treatment.
引用
收藏
页码:203 / 208
页数:6
相关论文
共 28 条
[1]   Consensus recommendations for the postmortem diagnosis of Alzheimer's disease [J].
Ball, M ;
Braak, H ;
Coleman, P ;
Dickson, D ;
Duyckaerts, C ;
Gambetti, P ;
Hansen, L ;
Hyman, B ;
Jellinger, K ;
Markesbery, W ;
Perl, D ;
Powers, J ;
Price, J ;
Trojanowski, JQ ;
Wisniewski, H ;
Phelps, C ;
Khachaturian, Z .
NEUROBIOLOGY OF AGING, 1997, 18 (04) :S1-S2
[2]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[3]   ANTEMORTEM DIAGNOSIS OF DIFFUSE LEWY BODY DISEASE [J].
CRYSTAL, HA ;
DICKSON, DW ;
LIZARDI, JE ;
DAVIES, P ;
WOLFSON, LI .
NEUROLOGY, 1990, 40 (10) :1523-1528
[4]   NEUROPATHOLOGIC AND CLINICAL-FEATURES OF PARKINSONS-DISEASE IN ALZHEIMERS-DISEASE PATIENTS [J].
DITTER, SM ;
MIRRA, SS .
NEUROLOGY, 1987, 37 (05) :754-760
[5]   CLINICAL HETEROGENEITY - RESPONDERS TO CHOLINERGIC THERAPY [J].
EAGGER, SA ;
HARVEY, RJ .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1995, 9 :37-42
[6]   REGIONAL VARIATION IN THE DISTRIBUTION OF APOLIPOPROTEIN-E AND A-BETA IN ALZHEIMERS-DISEASE [J].
GEARING, M ;
SCHNEIDER, JA ;
ROBINS, RS ;
HOLLISTER, RD ;
MORI, H ;
GAMES, D ;
HYMAN, BT ;
MIRRA, SS .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1995, 54 (06) :833-841
[7]  
HANSEN L, 1990, NEUROLOGY, V40, P1
[8]   PLAQUE-ONLY ALZHEIMER-DISEASE IS USUALLY THE LEWY BODY VARIANT, AND VICE-VERSA [J].
HANSEN, LA ;
MASLIAH, E ;
GALASKO, D ;
TERRY, RD .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1993, 52 (06) :648-654
[9]   Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies [J].
Hansen, LA ;
Samuel, W .
NEUROLOGY, 1997, 48 (01) :126-132
[10]   BIOLOGICAL AND NEUROPSYCHOLOGICAL CHARACTERIZATION OF PHYSOSTIGMINE RESPONDERS AND NONRESPONDERS IN ALZHEIMERS-DISEASE [J].
HARRELL, LE ;
JOPE, RS ;
FALGOUT, J ;
CALLAWAY, R ;
AVERY, C ;
SPIERS, M ;
LELI, D ;
MORERE, D ;
HALSEY, JH .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1990, 38 (02) :113-122